title: Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
abstract: BACKGROUND
  -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world.
  
  
  OBJECTIVE
  -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum. The dataset is composed of "required" (mandatory) and "recommended" (nonmandatory) elements.
  
  
  METHODS
  -Based on a review of the most recent evidence and supported by explanatory commentary.
  
  
  RESULTS
  -Eight required elements and 7 recommended elements were agreed upon by the Expert Panel to represent the essential information for reporting malignant mesothelioma of the pleura and peritoneum.
  
  
  CONCLUSIONS
  -In time, the widespread use of an internationally agreed upon, structured, pathology dataset for mesothelioma will lead not only to improved patient management but also provide valuable data for research and international benchmarks.
authors.affiliation: From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley).
authors.forename: Andrew
authors.initials: A
authors.lastname: Churg
authors.forename: Richard
authors.initials: R
authors.lastname: Attanoos
authors.forename: Alain C
authors.initials: AC
authors.lastname: Borczuk
authors.forename: Lucian R
authors.initials: LR
authors.lastname: Chirieac
authors.forename: Françoise
authors.initials: F
authors.lastname: Galateau-Sallé
authors.forename: Allen
authors.initials: A
authors.lastname: Gibbs
authors.forename: Douglas
authors.initials: D
authors.lastname: Henderson
authors.forename: Victor
authors.initials: V
authors.lastname: Roggli
authors.forename: Valerie
authors.initials: V
authors.lastname: Rusch
authors.forename: Meagan J
authors.initials: MJ
authors.lastname: Judge
authors.forename: John R
authors.initials: JR
authors.lastname: Srigley
mesh_terms: D044362:Australasia; D002170:Canada; D005060:Europe; D019317:Evidence-Based Medicine / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data; D017408:Guidelines as Topic / Q000592:standards; D006801:Humans; D007391:International Cooperation; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008654:Mesothelioma / Q000175:diagnosis / Q000628:therapy*; D000086002:Mesothelioma, Malignant; D000072142:Pathologists; D010338:Pathology, Clinical / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D010537:Peritoneum / Q000473:pathology*; D010994:Pleura / Q000473:pathology*; D058028:Research Report / Q000592:standards*; D012955:Societies, Medical; D006113:United Kingdom; D014481:United States